CGT

1,155개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,155 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

pCAR-19B cells (pCAR-19B cells)

Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleGreat Ormond Street Hospital fo…Phase 2

pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion (pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion)

Granulomatous Disease, Chronic, X-linked, Variant · CD3

#CD3#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Discontinued
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

peripheral blood progenitor cells carrying MDR1 (peripheral blood progenitor cells carrying MDR1)

Breast Neoplasms; Neoplasm Metastasis · Breast Neoplasms

#BreastNeoplasms#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleBeijing GoBroad HospitalPhase 1

prior-HSCT donor-derived FL-33 CAR T therapy (prior-HSCT donor-derived FL-33 CAR T therapy)

Refractory/Relapsed Acute Myeloid Leukaemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

prophylactic 4SCAR19 cells (prophylactic 4SCAR19 cells)

B Acute Lymphoblastic Leukemia · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleMyrtelle Inc.Phase 2

rAAV-Olig001-ASPA (rAAV-Olig001-ASPA)

Canavan Disease · Canavan Disease

#CanavanDisease#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleSTZ eyetrialPhase 2

rAAV.hCNGA3 (rAAV.hCNGA3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleLions Eye Institute, Perth, Wes…Phase 2

rAAV.sFlt-1 (rAAV.sFlt-1)

Macular Degeneration; Age-related Maculopathies · Macular Degeneration

#MacularDegeneration#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleMuscular Dystrophy AssociationPhase 1

rAAV1.tMCK.human-alpha-sarcoglycan- First cohort (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort)

Muscular Dystrophies · Muscular Dystrophies

#MuscularDystrophies#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 1

rAAV2-CB-hAAT Gene Vector (rAAV2-CB-hAAT Gene Vector)

Alpha 1-Antitrypsin Deficiency · Alpha 1-Antitrypsin Deficiency

#Alpha1-AntitrypsinDeficiency#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleBeacon TherapeuticsPhase 2

rAAV2-CB-hRPE65 (rAAV2-CB-hRPE65)

Leber Congenital Amaurosis · Leber Congenital Amaurosis

#LeberCongenitalAmaurosis#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

rAAV2-CBSB-hRPE65 (rAAV2-CBSB-hRPE65)

Amaurosis of Leber; Retinal Diseases · Amaurosis of Leber

#AmaurosisofLeber#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAskBio IncPhase 1

d3990 (rAAV2.5-CMV-minidystrophin, rAAV2.5-CMV-minidystrophin (d3990))

Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy

#DuchenneMuscularDystrophy#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUniversity of OxfordPhase 2

rAAV2.REP1 (rAAV2.REP1)

Choroideremia · Choroideremia

#Choroideremia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUniversity of AlbertaPhase 2

rAAV2.REP1 vector (rAAV2.REP1 vector)

Choroideremia · Choroideremia

#Choroideremia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleNantes University HospitalPhase 2

rAAV2/4.hRPE65 (rAAV2/4.hRPE65)

Leber Congenital Amaurosis · Leber Congenital Amaurosis

#LeberCongenitalAmaurosis#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 1 (rAAV2/5-PBGD vector dosage 1)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 2 (rAAV2/5-PBGD vector dosage 2)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 3 (rAAV2/5-PBGD vector dosage 3)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 4 (rAAV2/5-PBGD vector dosage 4)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active

57 / 58 pages

← PreviousNext →